Cancer chemotherapy targeted at reactivating the expression of epigenetically inactivated genes.
Jonathan E
JE
Dowell
John D
JD
Minna
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D019175:DNA Methylation; D004279:DNA, Viral / Q000378:metabolism*; D000077209:Decitabine; D004791:Enzyme Inhibitors / Q000494:pharmacology; D015870:Gene Expression; D020868:Gene Silencing; D018390:Gene Targeting; D004854:Herpesvirus 4, Human / Q000235:genetics*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D011401:Promoter Regions, Genetic
D000970:Antineoplastic Agents; D004279:DNA, Viral; D004791:Enzyme Inhibitors; D000077209:Decitabine; D001374:Azacitidine